Cite
HARVARD Citation
Richter, J. et al. (2023). Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma. Cancer medicine. pp. 8005-8017. [Online].